Evidence map›Paper›PMID 31591472›Full record

ArticleCell death and differentiation2020

Impaired adult neurogenesis is an early event in Alzheimer's disease neurodegeneration, mediated by intracellular Aβ oligomers.

Chiara Scopa, Francesco Marrocco, Valentina Latina, Federica Ruggeri, Valerio Corvaglia, Federico La Regina, Martine Ammassari-Teule, Silvia Middei, Giuseppina Amadoro, Giovanni Meli and 2 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cell death and differentiation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Boosting Neurogenesis as a Strategy in Treating Alzheimer's Disease.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Chiara ScopaDepartment of Science, University "Roma Tre", Roma, Italy.
Francesco MarroccoConsiglio Nazionale delle Ricerche (CNR), Institute of Cell Biology and Neurobiology, Roma, Italy.
Valentina LatinaEuropean Brain Research Institute (EBRI), Roma, Italy.
Federica RuggeriEuropean Brain Research Institute (EBRI), Roma, Italy.
Valerio CorvagliaEuropean Brain Research Institute (EBRI), Roma, Italy.
Federico La ReginaEuropean Brain Research Institute (EBRI), Roma, Italy.
Martine Ammassari-TeuleIRCSS Fondazione Santa Lucia, Roma, Italy.
Silvia MiddeiConsiglio Nazionale delle Ricerche (CNR), Institute of Cell Biology and Neurobiology, Roma, Italy.
Giuseppina AmadoroEuropean Brain Research Institute (EBRI), Roma, Italy.
Giovanni MeliEuropean Brain Research Institute (EBRI), Roma, Italy. g.meli@ebri.it.
Raffaella ScardigliEuropean Brain Research Institute (EBRI), Roma, Italy. raffaella.scardigli@cnr.it.
Antonino CattaneoEuropean Brain Research Institute (EBRI), Roma, Italy. antonino.cattaneo@sns.it.
European Brain Research Institute · ITNational Research Council · ITFondazione Santa Lucia · ITInstitute of Cell Biology and Neurobiology · ITIstituto di Farmacologia Traslazionale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alterations of adult neurogenesis have been reported in several Alzheimer's disease (AD) animal models and human brains, while defects in this process at presymptomatic/early stages of AD have not been explored yet. To address this, we investigated potential neurogenesis defects in Tg2576 transgenic mice at 1.5 months of age, a prodromal asymptomatic age in terms of Aβ accumulation and neurodegeneration. We observe that Tg2576 resident and SVZ-derived adult neural stem cells (aNSCs) proliferate significantly less. Further, they fail to terminally differentiate into mature neurons due to pathological, tau-mediated, and microtubule hyperstabilization. Olfactory bulb neurogenesis is also strongly reduced, confirming the neurogenic defect in vivo. We find that this phenotype depends on the formation and accumulation of intracellular A-beta oligomers (AβOs) in aNSCs. Indeed, impaired neurogenesis of Tg2576 progenitors is remarkably rescued both in vitro and in vivo by the expression of a conformation-specific anti-AβOs intrabody (scFvA13-KDEL), which selectively interferes with the intracellular generation of AβOs in the endoplasmic reticulum (ER). Altogether, our results demonstrate that SVZ neurogenesis is impaired already at a presymptomatic stage of AD and is caused by endogenously generated intracellular AβOs in the ER of aNSCs. From a translational point of view, impaired SVZ neurogenesis may represent a novel biomarker for AD early diagnosis, in association to other biomarkers. Further, this study validates intracellular Aβ oligomers as a promising therapeutic target and prospects anti-AβOs scFvA13-KDEL intrabody as an effective tool for AD treatment.

Indexed as

NeurogenesisProtein MultimerizationAlzheimer DiseaseAmyloid beta-PeptidesAnimalsCell DifferentiationCell ProliferationHumansIntracellular SpaceMice, TransgenicMicrotubulesNerve DegenerationNeural Stem CellsNeuronsOlfactory BulbProtein ConformationAmyloid beta-Peptides

Identifiers

PMID31591472
PMCPMC7206128
OpenAlexW2979089456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.